The Readout Loud
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
1
394: Eli Lilly's deal man, Allogene's off-the-s...
24 min
2
393: A conversation with the 'godfather' of bio...
44 min
3
392: Epstein's pal attempts a biotech comeback,...
29 min
4
391: Breaching the IBD efficacy ceiling, and sh...
29 min
5
390: FDA turmoil, election intrigue, AI, and more
31 min
6
389: Hims' Super Bowl fallout, and the FDA reve...
33 min
7
388: The FDA's refusal to review Moderna's mRNA...
50 min
8
387: Challenges for a crucial sickle cell treat...
27 min
9
From Drug Story: Lipitor and Heart Disease
61 min
10
386: The high stakes for Huntington's patients
40 min
11
385: A measles outbreak and hospitals' financia...
28 min
12
384: Live from the JP Morgan conference, a sit-...
67 min
13
383: JPM to bring more deals and happy CEOs
32 min
14
382: Biotech's year in review
33 min
15
381: The future of American science and a dispa...
32 min
16
380: A new top drug regulator and the future of...
31 min
17
379: How Mark Cuban plans to ‘f— up’ health care
36 min
18
378: Merck's heart disease win and the FDA's ne...
35 min
19
377: Melodrama at the FDA and the Pfizer-Novo b...
30 min
20
376: BridgeBio’s great week and Moderna’s unrav...
37 min
21
375: Startups push the FDA and biotech booms in...
28 min
22
374: Veteran biotech executive Clive Meanwell o...
33 min
23
373: Party in biotech land and AstraZeneca’s mi...
45 min
24
372: A pharma C-suite shakeup and Trump's deal ...
27 min
25
371: A gene therapy success in Huntington's and...
41 min